Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R DAVIS

Showing results (141-150 of 154) with videos related to

Pageof 16
Sort By:
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research GroupJ L Probstfield, W B Applegate, N O Borhani, et al.
Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.
Journal of Clinical Microbiology|January 1, 1985
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimensJ J Farmer, B R Davis, F W Hickman-Brenner, et al.
Annals of Internal Medicine|December 5, 1998
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trialS J Lewis, L A Moye, F M Sacks, et al.
Circulation|January 20, 1999
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care InvestigatorsJ F Plehn, B R Davis, F M Sacks, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage IIL M Fuller, N Q Mirza, J L Palmer, et al.
The New England Journal of Medicine|October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsF M Sacks, M A Pfeffer, L A Moye, et al.
Controlled Clinical Trials|December 12, 2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experienceJ T Wright, W C Cushman, B R Davis, et al.
Controlled Clinical Trials|February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)S L Pressel, B R Davis, J T Wright, et al.
The New England Journal of Medicine|March 24, 1983
Hemorrhagic colitis associated with a rare Escherichia coli serotypeL W Riley, R S Remis, S D Helgerson, et al.
Pageof 16

Showing results (141-150 of 154) with videos related to

Sort By:
Pageof 16
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1989
The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research GroupJ L Probstfield, W B Applegate, N O Borhani, et al.
Circulation|December 8, 1998
Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care InvestigatorsR B Goldberg, M J Mellies, F M Sacks, et al.
Journal of Clinical Microbiology|January 1, 1985
Biochemical identification of new species and biogroups of Enterobacteriaceae isolated from clinical specimensJ J Farmer, B R Davis, F W Hickman-Brenner, et al.
Annals of Internal Medicine|December 5, 1998
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trialS J Lewis, L A Moye, F M Sacks, et al.
Circulation|January 20, 1999
Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care InvestigatorsJ F Plehn, B R Davis, F M Sacks, et al.
International Journal of Radiation Oncology, Biology, Physics|February 11, 1998
Hodgkin's disease: correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with Stage I supradiaphragmatic presentations vs. those in patients with Stage IIL M Fuller, N Q Mirza, J L Palmer, et al.
The New England Journal of Medicine|October 3, 1996
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigatorsF M Sacks, M A Pfeffer, L A Moye, et al.
Controlled Clinical Trials|December 12, 2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): clinical center recruitment experienceJ T Wright, W C Cushman, B R Davis, et al.
Controlled Clinical Trials|February 13, 2001
Operational aspects of terminating the doxazosin arm of The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)S L Pressel, B R Davis, J T Wright, et al.
The New England Journal of Medicine|March 24, 1983
Hemorrhagic colitis associated with a rare Escherichia coli serotypeL W Riley, R S Remis, S D Helgerson, et al.
Pageof 16